Conditions: Asthma
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 108
Healthy volunteers: no

Brief summary:
To investigate the effectiveness and safety of BI 671800 given in the morning (AM), evening (PM) or twice daily (b.i.d.) compared too placebo as add on therapy to inhaled corticosteroid in symptomatic asthma patients.

Detailed description:

Arms:
arm 1: Patients receiving two capsules twice daily arm 2: Patients receiving four capsules in the morning arm 3: Patients receiving four capsules in the evening arm 4: Patients receiving four capsules twice a day

Interventions: intervention 1: BI 671800 intervention 2: Placebo
Intervention descriptions: intervention 1: BI 671800 intervention 2: Placebo matching BI 671800

Protocol document: